German Science & Technology Today
SEE OTHER BRANDS

Your best source on science and technology news from Germany

German Science & Technology Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on German Science & Technology Today.

Press releases published on June 20, 2025

Army Aviation and Missile Command (AMCOM) and Industry Tackle Hexavalent Chromium Hazards

Army Aviation and Missile Command (AMCOM) and Industry Tackle Hexavalent Chromium Hazards

by: (AMCOM)-G4 Mark G. Feathers, Environmental Engineer, Lead, and Physical Scientists Scott Howison, Jasmine Briant, and Ted Ventresca, President?COO CHEMEON MINDEN, NV, UNITED STATES, June 20, 2025 /⁨EINPresswire.com⁩/ -- In the hangars of Corpus …

SHELLEYES Partners with Ukraine’s Border Guard Service to Deploy S Eye Body Cameras for Enhanced Field Security

SHELLEYES Partners with Ukraine’s Border Guard Service to Deploy S Eye Body Cameras for Enhanced Field Security

The Main Center for Capital Construction, Reconstruction, and Procurement of the State Border Service of Ukraine purchased a batch of Body Cam from Shelleyes. SHENZHEN, CHINA, June 20, 2025 /⁨EINPresswire.com⁩/ -- SHELLEYES Partners with Ukraine’s Border …

MAIV Announces Strategic Investment and Advisory Partnership with Covey

MAIV Announces Strategic Investment and Advisory Partnership with Covey

BERLIN, June 20, 2025 (GLOBE NEWSWIRE) -- MAIV, the on-chain platform for private equity deals, is proud to announce a strategic investment and advisory partnership with Covey, a web3-native firm specializing in advisory, capital, development, and …

NurExone Advances U.S. Growth Strategy with Acceptance into Prestigious ARMI HealthTech Hub Accelerator and Provides Corporate Update

NurExone Advances U.S. Growth Strategy with Acceptance into Prestigious ARMI HealthTech Hub Accelerator and Provides Corporate Update

TORONTO and HAIFA, Israel, June 20, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biotech company developing exosome-based therapies for central nervous system injuries, announced …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service